Skip to main content

Table 2 Outcomes of the included studies

From: Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis

Study

N

Mean (SD) pregnancy duration (weeks)

Live birth events n (total n)

Intervention

Control

Intervention

Control

RR [95% CI]

p-value

Ahmadi et al. (2019)

78

39.1 (2.1)

38.3 (2.6)

33 (38)

18 (40)

1.93 [1.34, 2.78]

 < 0.001

Jafarzadeh et al. (2019)

94

Not reported

Not reported

38 (44)

21 (50)

2.06 [1.45, 2.91]

 < 0.001

Mahmoud et al. (2004)

15

Not reported

Not reported

5 (7)

6 (8)

0.95 [0.51, 1.76]

0.877

Moraru et al. (2012)

24

Not reported

Not reported

19 (20)

2 (4)

1.90 [0.71, 5.09]

0.202

Perricone et al. (2008)

24

37.5 (0.9)

37.2 (2.49)

12 (12)

9 (12)

1.32 [0.93, 1.86]

0.122

Ramos-Medina et al. (2014)

121

Not reported

Not reported

79 (82)

12 (39)

3.13 [1.95, 5.02]

 < 0.001

Stricker et al. (2005)

64

Not reported

Not reported

38 (44)

2 (20)

8.64 [2.31, 32.33]

0.001

Winger et al. (2008)

58

37.2 (3.6)

38.8 (1.0)

20 (37)

4 (21)

2.84 [1.12, 7.20]

0.028

  1. NK natural killer, SD standard deviation